PODD · Insulet Corp.
AI read · Good for PODD
The AI's read
International Omnipod sales rose 31.7%, and operating margin reached 22.5%. Drug Delivery sales were $5.5 million, compared with $836.6 million for Omnipod, despite a 22.7% drop. Management expects slower sales growth in 2027 and says rivals may take a few percentage points of market share. That risk matters, but strong current sales, higher profit, and a raised 2026 forecast make the positive reading stronger.